#Cannabis Science Pioneer Tikun Olam
Expands Partnership with MariMed (OTCQB: $MRMD), to Bring Branded Cannabis
Products to More U.S. MMJ States
Deal Combines Tikun Products &
Unparalleled Research with MariMed's Cultivation & Distribution Networks
NEWTON, MA and NEW YORK, NY - September 21, 2017
(Investorideas.com Newswire) Tikun Olam, the world pioneer in cannabis research,
and MariMed Inc. (OTCQB:MRMD),
a preeminent management company in the U.S. medical cannabis industry,
announced an expansion of their licensing agreement for Tikun Olam products to
be grown, manufactured and sold through MariMed's network of managed and
affiliated licensed facilities throughout the United States.
This new agreement brings Tikun Olam's premium cannabis
products, years of proprietary, peer-reviewed scientific research and
unprecedented clinical data collection to four additional MMJ-legal U.S.
states, its most expansive agreement to date. Tikun Olam and MariMed's
relationship began in 2015 with a pilot program in Delaware and marked the
first time that U.S. patients had access to the world's only cannabis strains
proven to deliver symptomatic relief for specific conditions including cancer,
PTSD, epilepsy, Crohn's Disease/Colitis, chronic pain and neuropathy to name a
few.
Read this news in full at http://www.investorideas.com/news/2017/marijuana/09212OTCQBMRMD.asp
Marijuana
/ Hemp Stocks
Like
Marijuana Stocks? View our Marijuana / Hemp Stocks Directory
Join our
Group on Linkedin - Marijuana / Hemp Stocks - News and Trends in Green Investing
Watch the 420 Cannabis Investor video
This news is published on the Investorideas.com
Newswire - a global digital news source for investors and business leaders
Disclaimer/Disclosure: Investorideas.com is a digital
publisher of third party sourced news, articles and equity research as well as
creates original content, including video, interviews and articles. Original
content created by investorideas is protected by copyright laws other than
syndication rights. Our site does not make recommendations for purchases or
sale of stocks, services or products. Nothing on our sites should be construed
as an offer or solicitation to buy or sell products or securities. All
investment involves risk and possible loss of investment. This site is
currently compensated for news publication and distribution, social media and
marketing, content creation and more. Contact each company directly regarding
content and press release questions. Disclosure is posted for each compensated
news release, content published /created if required but otherwise the news was
not compensated for and was published for the sole interest of our readers and
followers. More disclaimer info: http://www.investorideas.com/About/Disclaimer.asp
Additional info regarding BC
Residents and global Investors: Effective September 15 2008 - all BC investors
should review all OTC and Pink sheet listed companies for adherence in new
disclosure filings and filing appropriate documents with Sedar. Read for more
info: http://www.bcsc.bc.ca/release.aspx?id=6894.
Global investors must adhere to regulations of each country.
